140 related articles for article (PubMed ID: 19626632)
1. Detection of cervical metastases with (11)C-tyrosine PET in patients with squamous cell carcinoma of the oral cavity or oropharynx: A comparison with (18)F-FDG PET.
Krabbe CA; van der Werff-Regelink G; Pruim J; van der Wal JE; Roodenburg JL
Head Neck; 2010 Mar; 32(3):368-74. PubMed ID: 19626632
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET in squamous cell carcinoma of the oral cavity and oropharynx: a study on inter- and intraobserver agreement.
Krabbe CA; Pruim J; Scholtens AM; Roodenburg JL; Brouwers AH; Phan TT; Agool A; Dijkstra PU
J Oral Maxillofac Surg; 2010 Jan; 68(1):21-7. PubMed ID: 20006150
[TBL] [Abstract][Full Text] [Related]
3. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 18F-FDG PET/CT for diagnosing cervical nodal metastases in patients with oral cavity or oropharynx carcinoma.
Piao Y; Bold B; Tayier A; Ishida R; Omura K; Okada N; Shibuya H
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):933-8. PubMed ID: 19846326
[No Abstract] [Full Text] [Related]
5. FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases.
Krabbe CA; Dijkstra PU; Pruim J; van der Laan BF; van der Wal JE; Gravendeel JP; Roodenburg JL
Oral Oncol; 2008 Jan; 44(1):31-6. PubMed ID: 17306603
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
[TBL] [Abstract][Full Text] [Related]
7. Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx.
Krabbe CA; Balink H; Roodenburg JL; Dol J; de Visscher JG
Int J Oral Maxillofac Surg; 2011 Nov; 40(11):1263-70. PubMed ID: 21824748
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study.
Krabbe CA; Pruim J; Dijkstra PU; Balink H; van der Laan BF; de Visscher JG; Roodenburg JL
J Nucl Med; 2009 Dec; 50(12):1940-7. PubMed ID: 19910434
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
[TBL] [Abstract][Full Text] [Related]
10. Preoperative predictive model of cervical lymph node metastasis combining fluorine-18 fluorodeoxyglucose positron-emission tomography/computerized tomography findings and clinical factors in patients with oral or oropharyngeal squamous cell carcinoma.
Mochizuki Y; Omura K; Nakamura S; Harada H; Shibuya H; Kurabayashi T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):274-82. PubMed ID: 22668784
[TBL] [Abstract][Full Text] [Related]
11. Nodal spread of squamous cell carcinoma of the oral cavity detected with PET-tyrosine, MRI and CT.
Braams JW; Pruim J; Nikkels PG; Roodenburg JL; Vaalburg W; Vermey A
J Nucl Med; 1996 Jun; 37(6):897-901. PubMed ID: 8683307
[TBL] [Abstract][Full Text] [Related]
12. Is there an additive value of 18 F-FDG PET-CT to CT/MRI for detecting nodal metastasis in oropharyngeal squamous cell carcinoma patients with palpably negative neck?
Sohn B; Koh YW; Kang WJ; Lee JH; Shin NY; Kim J
Acta Radiol; 2016 Nov; 57(11):1352-1359. PubMed ID: 26013025
[TBL] [Abstract][Full Text] [Related]
13. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI.
Stuckensen T; Kovács AF; Adams S; Baum RP
J Craniomaxillofac Surg; 2000 Dec; 28(6):319-24. PubMed ID: 11465137
[TBL] [Abstract][Full Text] [Related]
14. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity.
Kim SY; Roh JL; Kim JS; Ryu CH; Lee JH; Cho KJ; Choi SH; Nam SY
Eur J Surg Oncol; 2008 Feb; 34(2):208-15. PubMed ID: 17482789
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma.
Pentenero M; Cistaro A; Brusa M; Ferraris MM; Pezzuto C; Carnino R; Colombini E; Valentini MC; Giovanella L; Spriano G; Gandolfo S
Head Neck; 2008 Nov; 30(11):1488-96. PubMed ID: 18767178
[TBL] [Abstract][Full Text] [Related]
16. Clinical values of (18) F-FDG PET/CT in oral cavity cancer with dental artifacts on CT or MRI.
Hong HR; Jin S; Koo HJ; Roh JL; Kim JS; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2014 Nov; 110(6):696-701. PubMed ID: 24995957
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.
Kim M; Higuchi T; Arisaka Y; Achmad A; Tokue A; Tominaga H; Miyashita G; Miyazaki H; Negishi A; Yokoo S; Tsushima Y
Ann Nucl Med; 2013 Jun; 27(5):423-30. PubMed ID: 23436243
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET in the clinically negative neck in oral squamous cell carcinoma.
Wensing BM; Vogel WV; Marres HA; Merkx MA; Postema EJ; Oyen WJ; van den Hoogen FJ
Laryngoscope; 2006 May; 116(5):809-13. PubMed ID: 16652093
[TBL] [Abstract][Full Text] [Related]
19. Is there a need for positron emission tomography imaging to stage the N0 neck in T1-T2 squamous cell carcinoma of the oral cavity or oropharynx?
Schroeder U; Dietlein M; Wittekindt C; Ortmann M; Stuetzer H; Vent J; Jungehuelsing M; Krug B
Ann Otol Rhinol Laryngol; 2008 Nov; 117(11):854-63. PubMed ID: 19102133
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]